Prolonged QTc in HIV-Infected Patients: A Need for Routine ECG Screening

Merle Myerson, Emma Kaplan-Lewis, Eduard Poltavskiy, David Ferris, Heejung Bang

Research output: Contribution to journalArticle

Abstract

BACKGROUND:: With HIV-infected patients living longer, there is an increased burden of comorbidities related to aging, HIV itself, and polypharmacy. Cardiac morbidity is of particular importance. METHODS:: This 2-group comparison study (156 HIV-positive and 105 HIV-negative patients) investigated the prevalence of abnormalities in and factors associated with an electrocardiogram (ECG) measure, corrected QT interval (QTc), where prolongation can lead to arrhythmia and sudden death. Medications prescribed (antiretroviral therapy, psychiatric medications, methadone, and antibiotics) at the time of ECG were noted. Patient characteristics, medications, QTc, and ECG characteristics were compared between the 2 groups. RESULTS:: Prolongation (29% versus 19%) and extreme prolongation (6% versus 1%) in QTc were more frequent in those with HIV. Antiretroviral therapy was associated with lower odds of prolonged QTc (odds ratio [OR] = 0.35; P = .04), while methadone with higher odds (OR = 4.6; P = .01) in HIV-positive patients. With methadone and medication groups adjusted, HIV status was still associated with 17-millisecond longer QTc ( P = .04). CONCLUSION:: This study provides evidence that patients with HIV may have clinically relevant longer QTc interval on ECG. Baseline and routine ECG monitoring may be warranted among patients living with HIV in clinical practice based on cumulative evidence.

Original languageEnglish (US)
JournalJournal of the International Association of Providers of AIDS Care
Volume18
DOIs
StatePublished - Jan 1 2019

Fingerprint

Electrocardiography
HIV
Methadone
Odds Ratio
Polypharmacy
Sudden Death
Psychiatry
Comorbidity
Cardiac Arrhythmias
Anti-Bacterial Agents
Morbidity
Therapeutics

Keywords

  • antiretroviral therapy
  • ECG
  • HIV
  • methadone
  • QT prolongation
  • QTc

ASJC Scopus subject areas

  • Immunology
  • Dermatology
  • Infectious Diseases

Cite this

Prolonged QTc in HIV-Infected Patients : A Need for Routine ECG Screening. / Myerson, Merle; Kaplan-Lewis, Emma; Poltavskiy, Eduard; Ferris, David; Bang, Heejung.

In: Journal of the International Association of Providers of AIDS Care, Vol. 18, 01.01.2019.

Research output: Contribution to journalArticle

@article{39a8352932404974ac734c4f1b3bb57d,
title = "Prolonged QTc in HIV-Infected Patients: A Need for Routine ECG Screening",
abstract = "BACKGROUND:: With HIV-infected patients living longer, there is an increased burden of comorbidities related to aging, HIV itself, and polypharmacy. Cardiac morbidity is of particular importance. METHODS:: This 2-group comparison study (156 HIV-positive and 105 HIV-negative patients) investigated the prevalence of abnormalities in and factors associated with an electrocardiogram (ECG) measure, corrected QT interval (QTc), where prolongation can lead to arrhythmia and sudden death. Medications prescribed (antiretroviral therapy, psychiatric medications, methadone, and antibiotics) at the time of ECG were noted. Patient characteristics, medications, QTc, and ECG characteristics were compared between the 2 groups. RESULTS:: Prolongation (29{\%} versus 19{\%}) and extreme prolongation (6{\%} versus 1{\%}) in QTc were more frequent in those with HIV. Antiretroviral therapy was associated with lower odds of prolonged QTc (odds ratio [OR] = 0.35; P = .04), while methadone with higher odds (OR = 4.6; P = .01) in HIV-positive patients. With methadone and medication groups adjusted, HIV status was still associated with 17-millisecond longer QTc ( P = .04). CONCLUSION:: This study provides evidence that patients with HIV may have clinically relevant longer QTc interval on ECG. Baseline and routine ECG monitoring may be warranted among patients living with HIV in clinical practice based on cumulative evidence.",
keywords = "antiretroviral therapy, ECG, HIV, methadone, QT prolongation, QTc",
author = "Merle Myerson and Emma Kaplan-Lewis and Eduard Poltavskiy and David Ferris and Heejung Bang",
year = "2019",
month = "1",
day = "1",
doi = "10.1177/2325958219833926",
language = "English (US)",
volume = "18",
journal = "Journal of the International Association of Providers of AIDS Care",
issn = "2325-9574",
publisher = "SAGE Publications Inc.",

}

TY - JOUR

T1 - Prolonged QTc in HIV-Infected Patients

T2 - A Need for Routine ECG Screening

AU - Myerson, Merle

AU - Kaplan-Lewis, Emma

AU - Poltavskiy, Eduard

AU - Ferris, David

AU - Bang, Heejung

PY - 2019/1/1

Y1 - 2019/1/1

N2 - BACKGROUND:: With HIV-infected patients living longer, there is an increased burden of comorbidities related to aging, HIV itself, and polypharmacy. Cardiac morbidity is of particular importance. METHODS:: This 2-group comparison study (156 HIV-positive and 105 HIV-negative patients) investigated the prevalence of abnormalities in and factors associated with an electrocardiogram (ECG) measure, corrected QT interval (QTc), where prolongation can lead to arrhythmia and sudden death. Medications prescribed (antiretroviral therapy, psychiatric medications, methadone, and antibiotics) at the time of ECG were noted. Patient characteristics, medications, QTc, and ECG characteristics were compared between the 2 groups. RESULTS:: Prolongation (29% versus 19%) and extreme prolongation (6% versus 1%) in QTc were more frequent in those with HIV. Antiretroviral therapy was associated with lower odds of prolonged QTc (odds ratio [OR] = 0.35; P = .04), while methadone with higher odds (OR = 4.6; P = .01) in HIV-positive patients. With methadone and medication groups adjusted, HIV status was still associated with 17-millisecond longer QTc ( P = .04). CONCLUSION:: This study provides evidence that patients with HIV may have clinically relevant longer QTc interval on ECG. Baseline and routine ECG monitoring may be warranted among patients living with HIV in clinical practice based on cumulative evidence.

AB - BACKGROUND:: With HIV-infected patients living longer, there is an increased burden of comorbidities related to aging, HIV itself, and polypharmacy. Cardiac morbidity is of particular importance. METHODS:: This 2-group comparison study (156 HIV-positive and 105 HIV-negative patients) investigated the prevalence of abnormalities in and factors associated with an electrocardiogram (ECG) measure, corrected QT interval (QTc), where prolongation can lead to arrhythmia and sudden death. Medications prescribed (antiretroviral therapy, psychiatric medications, methadone, and antibiotics) at the time of ECG were noted. Patient characteristics, medications, QTc, and ECG characteristics were compared between the 2 groups. RESULTS:: Prolongation (29% versus 19%) and extreme prolongation (6% versus 1%) in QTc were more frequent in those with HIV. Antiretroviral therapy was associated with lower odds of prolonged QTc (odds ratio [OR] = 0.35; P = .04), while methadone with higher odds (OR = 4.6; P = .01) in HIV-positive patients. With methadone and medication groups adjusted, HIV status was still associated with 17-millisecond longer QTc ( P = .04). CONCLUSION:: This study provides evidence that patients with HIV may have clinically relevant longer QTc interval on ECG. Baseline and routine ECG monitoring may be warranted among patients living with HIV in clinical practice based on cumulative evidence.

KW - antiretroviral therapy

KW - ECG

KW - HIV

KW - methadone

KW - QT prolongation

KW - QTc

UR - http://www.scopus.com/inward/record.url?scp=85063712429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063712429&partnerID=8YFLogxK

U2 - 10.1177/2325958219833926

DO - 10.1177/2325958219833926

M3 - Article

C2 - 30907255

AN - SCOPUS:85063712429

VL - 18

JO - Journal of the International Association of Providers of AIDS Care

JF - Journal of the International Association of Providers of AIDS Care

SN - 2325-9574

ER -